Prot# AZT-003: A Phase II Safety and Efficacy Study of ALZT-OP1a as Adjuvant Treatment in Subjects with Post-Ischemic Stroke Cognitive Impairment (PSCI)

Project: Research project

Project Details

StatusFinished
Effective start/end date11/22/16 → 11/22/20

Funding

  • AZTherapies, Inc. (Prot# AZT-003)